MS-BOCL@EC2609A

LEOCH INT'L

STARGLORY HLDGS

INTELLIMARK W27

BEST FOOD HLDG

GAOYU FINANCE

EXTREME VISION

TIAN TU CAPITAL

HSC RESOURCES

EPI (HOLDINGS)

LAP KEI ENGRG

601288

03968

601398

00939

512800

01288

01658

601939

516210

512700

515020

601988

517900

601998

03988

159887

01398

512820

As of April 2, 22 A-share listed banks have disclosed their 2025 profit distribution plans, with the six major state-owned banks planning to pay out over 420 billion yuan in dividends in total. China Merchants Bank proposes a dividend of 25.296 billion yuan, with a full-year total exceeding 50 billion yuan; CNCB and INDUSTRIAL BANK both plan to exceed 20 billion yuan. Among city commercial banks, with the exception of Bank of Zhengzhou, others show high enthusiasm for dividend payouts

Wallstreetcn

CM BANK

ICBC

China Merchants Bank

Bank Of Communications

INDUSTRIAL BANK

Hwabao WP CSI Banks ETF

PSBC

BANKCOMM

Huaan CSI Banks ETF

China Southern CSI Banks ETF

ChinaAMC CSI Banks ETF

Bank Of China

China Merchants CSI BANK AH Price ETF

CNCB

BANK OF CHINA

Fullgoal CSI 800 Banks ETF

WP CSI Banks ETF

Listed Banks Distribute Generous Dividends; High Yield Highlights Long-Term Allocation Value

01349

BACHY

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China

marketscreener

FUDANZHANGJIANG

ChinaAMC SSE STAR Biology and Medicine ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Bank of China

E Fund CSI 300 Health Care ETF

China Merchants CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

E Fund CSI Biotechnology Theme ETF

Guotai CSI Bio-medicine ETF

Fudan-Zhangjiang

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China

601818

China's central bank: adds 12 banks as digital yuan business operators - statement

Hua Xia Bank

Bank of Ningbo

NJBK

Bank Of Suzhou

CZBANK

SPD Bank

Bank Of Jiangsu

CEB Bank

CEB BANK

China's central bank: adds 12 banks as digital yuan business operators - statement

JP Morgan released investment ratings and target prices for domestic bank stocks. The rating for MINSHENG BANK was adjusted from overweight to neutral, with the target price lowered from 4.4 yuan to 4 yuan; the rating for CEB BANK was adjusted from neutral to underweight, with the target price lowered from 3.1 yuan to 2.7 yuan; BANK OF CHINA, CCB, ICBC, BANKCOMM, and ABC all maintained overweight ratings, with target prices of 5.5 yuan, 9.5 yuan, 7.35 yuan, 7.85 yuan, and 6.1 yuan respectively; PSBC maintained a neutral rating with a target price of 5.5 yuan

AASTOCKS

CMBC

MINSHENG BANK

JP Morgan's investment ratings and target prices for domestic bank stocks (Table)

Morgan Stanley released a report predicting the dividend returns of Hong Kong-listed Chinese banks in 2026 and 2027. Agricultural Bank of China, Industrial and Commercial Bank of China, China Construction Bank, Bank of China, Postal Savings Bank of China, China Merchants Bank, and CITIC Bank are all rated as overweight, with dividend returns ranging from 5.3 cents to 6.2 cents. Bank of Communications and CEB Bank are rated as underweight, with dividend returns of 5.2 cents to 7.8 cents, respectively

CITIC BANK

Morgan Stanley lists the dividend return forecast for Hong Kong H-shares of domestic banks for the next two years (table)

Fitch Ratings has assigned a long-term issuer default rating of "A" to Bank of China Group Investment Limited (BOCIG), with a stable outlook. BOCIG is a wholly-owned subsidiary of Bank of China, primarily responsible for overseas direct investment, supporting infrastructure and green energy development. Fitch also assigned an "A" rating to Amipeace Limited's $1.2 billion medium-term note program, which is guaranteed by BOCIG. The rating of BOCIG is consistent with that of Bank of China, reflecting its core role in supporting national strategies and investments. It is expected that BOCIG's leverage ratio will remain stable in 2025

Fitch assigns Bank of China Investment an 'A' credit rating with a stable outlook

04621

Export-Import Bank issued 2-year bonds worth 2 billion yuan at a coupon rate of 1.4800%, with an expected rate of 1.4600%, a bid-to-cover ratio of 4.42, and a marginal ratio of 1.58. Concurrently, it issued 3-year bonds worth 3 billion yuan at a coupon rate of 1.5028%, with an expected rate of 1.5300%, a bid-to-cover ratio of 3.80, and a marginal ratio of 3.67

CINDA 21USDPREF

E Fund CSI 300 Financials (ex Banks) ETF

Bank of China (SEHK:3988) reported FY 2025 results with Q4 revenue of C¥146.5b and basic EPS of C¥0.19. The bank's trailing net profit margin is 41%, with a net interest margin of 1.26%. Total loans reached C¥23.4b, with non-performing loans at C¥288.0b. The DCF fair value is HK$10.03 per share, while the current share price is HK$4.97. Analysts forecast revenue growth of 9.7% per year and a dividend yield of 5.17%. Investors are divided on the stock's valuation amid rising credit concerns and tighter margins.

Simplywall

Bank Of China (SEHK:3988) Net Interest Margin Squeeze Tests Bullish Valuation Narratives

Bank of China (OTCMKTS:BACHY) reported its quarterly earnings, posting $0.67 earnings per share, matching analysts' expectations. The bank's revenue reached $23.66 billion, exceeding the consensus estimate of $20.13 billion. It recorded a net margin of 19.65% and a return on equity of 7.81%. Despite these results, shares of BACHY fell by 1.4%, opening at $15.13. The bank, a major state-owned institution in China, offers a wide range of banking services and has a market cap of $195 billion.

Market Beat

Bank of China (OTCMKTS:BACHY) Issues Earnings Results

Hong Kong stocks fluctuated positively today, with the Hang Seng Index closing at 24,788 points, up 37 points. The performance of domestic bank stocks was strong, with BOC Hong Kong's share price rising over 5%. The total market turnover was HKD 255.76 billion, with a net inflow of southbound funds of HKD 703 million. Despite declines in the share prices of CNOOC and Yangtze Optical Fibre and Cable, some bank stocks, such as Agricultural Bank of China and Bank of China, saw increases. Overall, the Hang Seng Index fell by 842 points in the first quarter, while the National Index and Hang Seng Tech Index also experienced varying degrees of decline

Guotai CSI All Share Investment Banking & Brokerage ETF

GF Fund CSI HK Connect Financials(ex Banks) Thematic ETF

BOC HONG KONG

ChinaAMC SSE Financials Sector ETF Initiating Fund

Hang Seng Index

Hwabao WP CSI All Share Investment Banking & Brokerage ETF

The Hong Kong stock market shows a fluctuating improvement, with Chinese bank stocks rising, and BOC Hong Kong bouncing over 5%

Bank of China announced its performance, with a pre-tax net profit growth of 2.2% year-on-year, operating income of RMB 659.866 billion, and net profit of RMB 243.021 billion. Citigroup has given Bank of China a "Buy" rating, with a target price of RMB 5.92. Non-interest income grew by 19.21%, accounting for 33.21% of operating income. The core Tier 1 capital adequacy ratio is 12.53%

The article "After the Performance" summarizes the latest ratings, target prices, and opinions from major institutions following the performance announcement of Bank of China

00005

HSBC Global Research report indicates that Bank of China’s earnings per share in 2025 will exceed expectations, benefiting from growth in assets, net interest income, and investment income, with mortgage asset quality superior to peers. Although the net interest margin of domestic operations is slightly lower than peers, the core Tier 1 capital ratio CET1 has seen a significant decline. The rating is maintained at "Buy," with the target price raised from 5.5 yuan to 5.7 yuan, and the earnings per share forecast for 2026 is increased by 2.4%, while the 2027 forecast is raised by 1.9%, with a new forecast added for 2028

HSBC HOLDINGS

HSBC Research raises Bank of China's target price to 5.7 yuan and increases earnings per share forecast

STECH

03692

03320

The Hang Seng Index closed at 24,624 points, down 126 points or 0.5%; the Hang Seng TECH Index reported 4,646 points, down 44 points or 0.9%. The National Index fell 70 points or 0.8%, closing at 8,328 points. Among the actively traded blue-chip stocks, HANSOH PHARMA rose over 6%, while Xiaomi, Alibaba, Meituan, and others experienced varying degrees of decline. Overall market performance was weak, with some individual stocks like BYD Electronics and Xinyi Glass seeing significant drops

Hang Seng TECH Index

HANSOH PHARMA

CHINARES PHARMA

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

E Fund Hang Seng SCHK Innovative Drug ETF

ChinaAMC Hang Seng Technology ETF(QDII)

Huatai-PB CSOP Hang Seng Technology ETF(QDII)

GF CSI HK Innovative Drugs Industry ETF(QDII)

Tianhong Hang Seng TECH ETF(QDII)

Hang Seng TECH ETF I

CSOP HS TECH

Dacheng Hang Seng Technology ETF(QDII)

China Southern Hang Seng Biotech ETF(QDII)

The "Half-Day Express" reported that the Hang Seng Index closed at 24,624 points, down 126 points; the Hang Seng TECH Index closed at 4,646 points, down 44 points. HANSOH PHARMA rose over 6%, while Bank Of China, ICBC, Guangdong Investment, Guofu Quantum, and CHINARES PHARMA reached new highs

$XTALPI(02228.HK) Yesterday, Bank of China Hong Kong made a large number of &#34;buy&#34; orders, which should be depository receipts. It was probably a previous shareholder, such as China Life Insurance (I remember there was a similar shareholder) with holdings of approximately 235,560,969 shares, accounting for 5.86%. Comparing the number of shares transferred by BOC Hong Kong yesterday: 235 million shares. It's roughly the same. Since China Life Insurance is a state-owned enterprise, the probability of using BOC Hong Kong is the highest. I roughly guess it's their depository. It's likely that Pharmaron issued them stock certificates, converting paper certificates into electronic shares.

Bank of CN HK SDR 1to1

MS-BOCL@EC2609A(27500.HK)

MS-BOCL@EC2609A Stock Performance Chart

Listed Banks Distribute Generous Dividends; High Yield Highlights Long-Term Allocation Value

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes to structured deposit product under Bank of China

China's central bank: adds 12 banks as digital yuan business operators - statement

JP Morgan's investment ratings and target prices for domestic bank stocks (Table)

Morgan Stanley lists the dividend return forecast for Hong Kong H-shares of domestic banks for the next two years (table)